Oral herpes drug developer Squarex Pharmaceuticals files for $15M IPO

Jan. 18, 2023 7:48 PM ETSquarex Pharmaceutical Corporation (SQRX)By: Val Kennedy, SA News Editor1 Comment

Man without head standing Catching Pose Visual arrow Showing uptrend with IPO text on Blue tone with Len Flare. Initial public offering.


Squarex Pharmaceuticals (SQRX) has filed to raise $15M through an initial public offering to help fund development of its product to prevent cold sore outbreaks.

The biotech company didn't specify in its filing how many shares it intended

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.